Innovent Biologics, Inc. (1801.HK) HKSE

87.20

+0.35(+0.40%)

Updated at October 20 09:35AM

Currency In HKD

Valuation

Market Cap55.94B
Enterprise Value51.27B
P/E Ratio119.76
PEG Ratio0.1
Price/Sales Ratio11.92
Price/Book Ratio9.4
Enterprise/Revenue11.38
Enterprise/EBITDA196.67

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.1
Operating Margin0.06

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue9.42B
Revenue/Share6.71
Gross Profit7.91B
EBITDA-480.28M
Net Income-94.63M
Diluted EPS-0.06

Balance Sheet

Total Cash9.54B
Total Cash/Share5.6
Total Debt3.38B
Total Debt/Equity0.23
Current Ratio2.61
Book Value Per Share8.47

Price History

52-Week Change90.67
52-Week High109.1
52-Week Low28.65
Moving Average 50 Days95.99
Moving Average 200 Days65.66

Statistics

Average Volume19.77M
Shares Outstanding1.71B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A